Cargando…

Aseptic loosening after total hip arthroplasty and the risk of cardiovascular disease: A nested case-control study

BACKGROUND: Patients with surgically treated osteoarthritis of the hip have an increased risk of cardiovascular morbidity and mortality many years after the operation compared with controls. Our hypothesis is that this increased risk after total hip arthroplasty (THA) is mediated by development of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Rysinska, Agata, Sköldenberg, Olof, Garland, Anne, Rolfson, Ola, Aspberg, Sara, Eisler, Thomas, Garellick, Göran, Stark, Andreas, Hailer, Nils, Gordon, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235257/
https://www.ncbi.nlm.nih.gov/pubmed/30427844
http://dx.doi.org/10.1371/journal.pone.0204391
_version_ 1783370844411527168
author Rysinska, Agata
Sköldenberg, Olof
Garland, Anne
Rolfson, Ola
Aspberg, Sara
Eisler, Thomas
Garellick, Göran
Stark, Andreas
Hailer, Nils
Gordon, Max
author_facet Rysinska, Agata
Sköldenberg, Olof
Garland, Anne
Rolfson, Ola
Aspberg, Sara
Eisler, Thomas
Garellick, Göran
Stark, Andreas
Hailer, Nils
Gordon, Max
author_sort Rysinska, Agata
collection PubMed
description BACKGROUND: Patients with surgically treated osteoarthritis of the hip have an increased risk of cardiovascular morbidity and mortality many years after the operation compared with controls. Our hypothesis is that this increased risk after total hip arthroplasty (THA) is mediated by development of periprosthetic osteolysis leading to aseptic loosening of the implant. METHODS: We conducted a nation-wide, nested, case-control study consisting of patients receiving a cemented THA due to osteoarthritis between the years 1992 and 2005. Our study population included a total of 14,430 subjects identified in the Swedish hip arthroplasty register and linked to the Swedish National Patient Register. The case group consisted of patients (n = 2,886) who underwent reoperation of the treated hip due to osteolysis or aseptic loosening at any time within five years after the index surgery. Each case was matched with four controls (n = 11,544) who had not undergone reoperation. The main outcomes were cardiovascular events i.e. myocardial infarction, heart failure and cerebral infarction according to ICD-codes and time to the first cardiovascular event during the exposure period. Outcomes were subgrouped into cardiac and cerebral events. We used regression models to calculate the incidence rates and adjusted our results for confounders. FINDINGS: Overall, 5.1% of patients had cardiac events, with slightly more overall cardiovascular events occurring in the control group (8.1% vs. 6.7%, odds ratio 0.8, 95% confidence interval (CI) 0.7 to 1.0). After adjusting for confounders, the case group had an increased relative risk of 1.3 (95% confidence interval (CI) 1.1 to 1.3) for total number of cardiovascular events. Similar effect sizes were observed for time to first event. INTERPRETATION: Patients with osteoarthritis who received THA and subsequently underwent a revision operation due to loosening had a higher relative risk of developing cardiovascular events than controls. Thus there is an association which could be explained by a common inflammatory disease pathway that requires further experimental research.
format Online
Article
Text
id pubmed-6235257
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-62352572018-12-01 Aseptic loosening after total hip arthroplasty and the risk of cardiovascular disease: A nested case-control study Rysinska, Agata Sköldenberg, Olof Garland, Anne Rolfson, Ola Aspberg, Sara Eisler, Thomas Garellick, Göran Stark, Andreas Hailer, Nils Gordon, Max PLoS One Research Article BACKGROUND: Patients with surgically treated osteoarthritis of the hip have an increased risk of cardiovascular morbidity and mortality many years after the operation compared with controls. Our hypothesis is that this increased risk after total hip arthroplasty (THA) is mediated by development of periprosthetic osteolysis leading to aseptic loosening of the implant. METHODS: We conducted a nation-wide, nested, case-control study consisting of patients receiving a cemented THA due to osteoarthritis between the years 1992 and 2005. Our study population included a total of 14,430 subjects identified in the Swedish hip arthroplasty register and linked to the Swedish National Patient Register. The case group consisted of patients (n = 2,886) who underwent reoperation of the treated hip due to osteolysis or aseptic loosening at any time within five years after the index surgery. Each case was matched with four controls (n = 11,544) who had not undergone reoperation. The main outcomes were cardiovascular events i.e. myocardial infarction, heart failure and cerebral infarction according to ICD-codes and time to the first cardiovascular event during the exposure period. Outcomes were subgrouped into cardiac and cerebral events. We used regression models to calculate the incidence rates and adjusted our results for confounders. FINDINGS: Overall, 5.1% of patients had cardiac events, with slightly more overall cardiovascular events occurring in the control group (8.1% vs. 6.7%, odds ratio 0.8, 95% confidence interval (CI) 0.7 to 1.0). After adjusting for confounders, the case group had an increased relative risk of 1.3 (95% confidence interval (CI) 1.1 to 1.3) for total number of cardiovascular events. Similar effect sizes were observed for time to first event. INTERPRETATION: Patients with osteoarthritis who received THA and subsequently underwent a revision operation due to loosening had a higher relative risk of developing cardiovascular events than controls. Thus there is an association which could be explained by a common inflammatory disease pathway that requires further experimental research. Public Library of Science 2018-11-14 /pmc/articles/PMC6235257/ /pubmed/30427844 http://dx.doi.org/10.1371/journal.pone.0204391 Text en © 2018 Rysinska et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Rysinska, Agata
Sköldenberg, Olof
Garland, Anne
Rolfson, Ola
Aspberg, Sara
Eisler, Thomas
Garellick, Göran
Stark, Andreas
Hailer, Nils
Gordon, Max
Aseptic loosening after total hip arthroplasty and the risk of cardiovascular disease: A nested case-control study
title Aseptic loosening after total hip arthroplasty and the risk of cardiovascular disease: A nested case-control study
title_full Aseptic loosening after total hip arthroplasty and the risk of cardiovascular disease: A nested case-control study
title_fullStr Aseptic loosening after total hip arthroplasty and the risk of cardiovascular disease: A nested case-control study
title_full_unstemmed Aseptic loosening after total hip arthroplasty and the risk of cardiovascular disease: A nested case-control study
title_short Aseptic loosening after total hip arthroplasty and the risk of cardiovascular disease: A nested case-control study
title_sort aseptic loosening after total hip arthroplasty and the risk of cardiovascular disease: a nested case-control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235257/
https://www.ncbi.nlm.nih.gov/pubmed/30427844
http://dx.doi.org/10.1371/journal.pone.0204391
work_keys_str_mv AT rysinskaagata asepticlooseningaftertotalhiparthroplastyandtheriskofcardiovasculardiseaseanestedcasecontrolstudy
AT skoldenbergolof asepticlooseningaftertotalhiparthroplastyandtheriskofcardiovasculardiseaseanestedcasecontrolstudy
AT garlandanne asepticlooseningaftertotalhiparthroplastyandtheriskofcardiovasculardiseaseanestedcasecontrolstudy
AT rolfsonola asepticlooseningaftertotalhiparthroplastyandtheriskofcardiovasculardiseaseanestedcasecontrolstudy
AT aspbergsara asepticlooseningaftertotalhiparthroplastyandtheriskofcardiovasculardiseaseanestedcasecontrolstudy
AT eislerthomas asepticlooseningaftertotalhiparthroplastyandtheriskofcardiovasculardiseaseanestedcasecontrolstudy
AT garellickgoran asepticlooseningaftertotalhiparthroplastyandtheriskofcardiovasculardiseaseanestedcasecontrolstudy
AT starkandreas asepticlooseningaftertotalhiparthroplastyandtheriskofcardiovasculardiseaseanestedcasecontrolstudy
AT hailernils asepticlooseningaftertotalhiparthroplastyandtheriskofcardiovasculardiseaseanestedcasecontrolstudy
AT gordonmax asepticlooseningaftertotalhiparthroplastyandtheriskofcardiovasculardiseaseanestedcasecontrolstudy